376 related articles for article (PubMed ID: 34457116)
1. Roles of the Immune/Methylation/Autophagy Landscape on Single-Cell Genotypes and Stroke Risk in Breast Cancer Microenvironment.
Wu JY; Qin J; Li L; Zhang KD; Chen YS; Li Y; Jin T; Xu JM
Oxid Med Cell Longev; 2021; 2021():5633514. PubMed ID: 34457116
[TBL] [Abstract][Full Text] [Related]
2. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
3. An integrative microenvironment approach for laryngeal carcinoma: the role of immune/methylation/autophagy signatures on disease clinical prognosis and single-cell genotypes.
Kang X; Chen Y; Yi B; Yan X; Jiang C; Chen B; Lu L; Sun Y; Shi R
J Cancer; 2021; 12(14):4148-4171. PubMed ID: 34093817
[TBL] [Abstract][Full Text] [Related]
4. CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment.
Chen Y; Meng Z; Zhang L; Liu F
Front Immunol; 2021; 12():664845. PubMed ID: 33968066
[TBL] [Abstract][Full Text] [Related]
5. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.
Li W; Sang M; Hao X; Jia L; Wang Y; Shan B
J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblast-derived gene signature discriminates distinct prognoses by integrated single-cell and bulk RNA-seq analyses in breast cancer.
Fang Z; Han YL; Gao ZJ; Yao F
Aging (Albany NY); 2024 May; 16(9):8279-8305. PubMed ID: 38728370
[TBL] [Abstract][Full Text] [Related]
7. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
8. Emerging immune gene signatures as prognostic or predictive biomarkers in breast cancer.
Kwon MJ
Arch Pharm Res; 2019 Nov; 42(11):947-961. PubMed ID: 31707598
[TBL] [Abstract][Full Text] [Related]
9. Recognition of Immune Microenvironment Landscape and Immune-Related Prognostic Genes in Breast Cancer.
Wang H; You S; Fang M; Fang Q
Biomed Res Int; 2020; 2020():3909416. PubMed ID: 33274208
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer.
Chen XQ; Zhang F; Xiao FH; Peng Y
Breast Cancer; 2021 Nov; 28(6):1252-1260. PubMed ID: 33966175
[TBL] [Abstract][Full Text] [Related]
11. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
[TBL] [Abstract][Full Text] [Related]
12. Subtype-specific risk models for accurately predicting the prognosis of breast cancer using differentially expressed autophagy-related genes.
Han B; Zhang H; Zhu Y; Han X; Wang Z; Gao Z; Yuan Y; Tian R; Zhang F; Niu R
Aging (Albany NY); 2020 Jul; 12(13):13318-13337. PubMed ID: 32649310
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
Liu J; Xu W; Li S; Sun R; Cheng W
Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
[No Abstract] [Full Text] [Related]
14. Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.
Ma Y; Du J; Chen M; Gao N; Wang S; Mi Z; Wei X; Zhao J
Front Immunol; 2023; 14():1219652. PubMed ID: 37457713
[TBL] [Abstract][Full Text] [Related]
15. Integrative pathway-based survival prediction utilizing the interaction between gene expression and DNA methylation in breast cancer.
Kim SY; Kim TR; Jeong HH; Sohn KA
BMC Med Genomics; 2018 Sep; 11(Suppl 3):68. PubMed ID: 30255812
[TBL] [Abstract][Full Text] [Related]
16. Eight immune-related genes predict survival outcomes and immune characteristics in breast cancer.
Xu H; Wang G; Zhu L; Liu H; Li B
Aging (Albany NY); 2020 Aug; 12(16):16491-16513. PubMed ID: 32756008
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Significance of the Oncotype DX Recurrence Score in T
Wang M; Wu K; Zhang P; Zhang M; Ding A; Chen H
Ann Surg Oncol; 2019 May; 26(5):1227-1235. PubMed ID: 30456680
[TBL] [Abstract][Full Text] [Related]
18. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
19. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
20. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
Liu D; Zhou K
Clin Breast Cancer; 2020 Feb; 20(1):41-50.e8. PubMed ID: 31547956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
